Qingdao Haier Biomedical Co.,Ltd (SHA:688139)
China
· Delayed Price · Currency is CNY 32.71
-0.24 (-0.73%)
At close: Apr 29, 2026
SHA:688139 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 10,271 | 9,924 | 11,112 | 12,824 | 20,078 | 28,796 | Upgrade
|
| Market Cap Growth | -5.58% | -10.69% | -13.35% | -36.13% | -30.28% | 39.10% | Upgrade
|
| Enterprise Value | 9,257 | 8,845 | 9,530 | 10,935 | 17,327 | 25,931 | Upgrade
|
| Last Close Price | 32.95 | 31.78 | 34.67 | 39.39 | 61.04 | 86.98 | Upgrade
|
| PE Ratio | 41.19 | 39.58 | 30.31 | 31.58 | 33.42 | 34.08 | Upgrade
|
| Forward PE | 32.95 | 19.67 | 17.53 | 18.53 | 25.87 | 39.80 | Upgrade
|
| PS Ratio | 4.41 | 4.26 | 4.87 | 5.62 | 7.01 | 13.55 | Upgrade
|
| PB Ratio | 2.22 | 2.15 | 2.41 | 2.89 | 4.84 | 7.91 | Upgrade
|
| P/TBV Ratio | 3.15 | 3.05 | 3.46 | 3.98 | 6.17 | 9.42 | Upgrade
|
| P/FCF Ratio | 69.10 | 66.77 | 67.36 | 177.91 | 59.37 | 74.39 | Upgrade
|
| P/OCF Ratio | 38.34 | 37.04 | 38.10 | 51.45 | 31.75 | 48.66 | Upgrade
|
| EV/Sales Ratio | 3.98 | 3.80 | 4.17 | 4.79 | 6.05 | 12.20 | Upgrade
|
| EV/EBITDA Ratio | 29.95 | 29.12 | 22.55 | 26.63 | 27.65 | 52.80 | Upgrade
|
| EV/EBIT Ratio | 47.28 | 45.18 | 31.08 | 34.94 | 30.69 | 58.67 | Upgrade
|
| EV/FCF Ratio | 62.28 | 59.51 | 57.77 | 151.70 | 51.24 | 66.99 | Upgrade
|
| Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0.00 | 0.01 | 0.00 | Upgrade
|
| Debt / EBITDA Ratio | 0.10 | 0.10 | 0.05 | 0.04 | 0.04 | 0.01 | Upgrade
|
| Debt / FCF Ratio | 0.20 | 0.20 | 0.14 | 0.25 | 0.08 | 0.02 | Upgrade
|
| Net Debt / Equity Ratio | -0.27 | -0.27 | -0.38 | -0.43 | -0.71 | -0.80 | Upgrade
|
| Net Debt / EBITDA Ratio | -4.15 | -4.15 | -4.15 | -4.63 | -4.71 | -5.90 | Upgrade
|
| Net Debt / FCF Ratio | -8.49 | -8.49 | -10.64 | -26.39 | -8.72 | -7.49 | Upgrade
|
| Asset Turnover | 0.40 | 0.40 | 0.40 | 0.41 | 0.55 | 0.48 | Upgrade
|
| Inventory Turnover | 3.67 | 3.67 | 4.09 | 4.53 | 4.84 | 3.58 | Upgrade
|
| Quick Ratio | 1.61 | 1.61 | 2.09 | 2.27 | 2.68 | 2.69 | Upgrade
|
| Current Ratio | 2.45 | 2.45 | 2.59 | 2.69 | 2.95 | 3.02 | Upgrade
|
| Return on Equity (ROE) | 5.52% | 5.52% | 8.41% | 9.60% | 15.72% | 26.44% | Upgrade
|
| Return on Assets (ROA) | 2.11% | 2.11% | 3.39% | 3.55% | 6.79% | 6.25% | Upgrade
|
| Return on Invested Capital (ROIC) | 5.70% | 6.06% | 10.76% | 15.88% | 52.76% | 60.40% | Upgrade
|
| Return on Capital Employed (ROCE) | 4.20% | 4.20% | 6.40% | 6.80% | 13.10% | 11.80% | Upgrade
|
| Earnings Yield | 2.44% | 2.53% | 3.30% | 3.17% | 2.99% | 2.94% | Upgrade
|
| FCF Yield | 1.45% | 1.50% | 1.49% | 0.56% | 1.68% | 1.34% | Upgrade
|
| Dividend Yield | 1.00% | 1.04% | 1.36% | 1.31% | 0.74% | 0.57% | Upgrade
|
| Payout Ratio | 58.77% | 58.77% | 44.48% | 35.16% | 27.04% | 14.30% | Upgrade
|
| Buyback Yield / Dilution | 0.84% | 0.84% | 0.37% | 0.20% | -0.06% | 2.43% | Upgrade
|
| Total Shareholder Return | 1.84% | 1.88% | 1.73% | 1.51% | 0.68% | 3.01% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.